Specific bypass conditions determine safe minimum flow rate.
BACKGROUND
The purpose of this study is to define a safe minimum flow rate for specific bypass conditions using continuous monitoring with near-infrared spectroscopy and direct observation of the cerebral microcirculation.


METHODS
Two series of experiments (n = 72 in each) were conducted in which piglets were cooled to a temperature of 15 degrees, 25 degrees, or 34 degrees C on cardiopulmonary bypass with hematocrit 20% or 30%, pH-stat management in all, followed by 1 or 2 hours of reduced flow (10, 25, or 50 mL.kg(-1).min(-1)). Animals in series one had a cranial window placed over the parietal cortex to evaluate the microcirculation with intravital microscopy. Plasma was labeled with fluorescein-isothiocyanate-dextran for assessment of functional capillary density (FCD) and microvascular diameter. In series two, near-infrared spectroscopy was utilized to detect tissue oxygenation index (TOI). Outcome measures included histologic and neurologic injury scores.


RESULTS
The TOI during low flow and FCD during rewarming and after weaning from cardiopulmonary bypass were associated with neurologic injury. Failure of FCD to return to baseline during rewarming predicted worse functional and histologic outcome (p < 0.001). Regression analysis indicated that temperature and low-flow rate were multivariable predictors of TOI and FCD during rewarming (p < 0.001).


CONCLUSIONS
Tissue oxygen index derived from near-infrared spectroscopy is a useful real-time monitor for detecting inadequate cerebral perfusion during cardiopulmonary bypass. Minimal safe pump flow rate varies according to the conditions of bypass: using pH stat management and with an hematocrit of either 20% or 30%, a flow rate as low as 10 mL.kg(-1).min(-1) is safe for as long as 2 hours at a temperature of 15 degrees C. However, under the same conditions at 34 degrees C, a flow rate of 10 mL.kg(-1).min(-1) is very likely to be associated with neurologic injury.
Anttila
Vesa
V
Department of Pathology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA.
Hagino
Ikuo
I
Zurakowski
David
D
Iwata
Yusuke
Y
Duebener
Lennart
L
Lidov
Hart G W
HG
Jonas
Richard A
RA
D000818:Animals; D001783:Blood Flow Velocity; D002196:Capillaries / Q000473:pathology / Q000503:physiopathology; D002315:Cardiopulmonary Bypass / Q000009:adverse effects / Q000379:methods*; D002560:Cerebrovascular Circulation; D004195:Disease Models, Animal; D006400:Hematocrit; D008833:Microcirculation / Q000503:physiopathology; D009422:Nervous System Diseases / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D019265:Spectroscopy, Near-Infrared / Q000379:methods; D016019:Survival Analysis; D013552:Swine; D013696:Temperature; D016896:Treatment Outcome